National Library of Medicine (NCBI)
A. Muneer, Marco Bandini, Éva Compérat, Gert De Meerleer, Karim Fizazi, Jourik A. Gietema, Silke Gillessen, Alex Kirkham, Vijay Sangar, Constantine Alifrangis, Tom Powles,
... Lam W. Bolgeri M. et al.Treatment of carcinoma in situ of the glans penis with topical chemotherapy agents. ... S. Meinhardt W. et al.Laser therapy for carcinoma in situ of the penis.J Urol. 2001; 166: 1670- ... S.R. et al.Surgical management of penile carcinoma in situ: results from an international collaborative study and review ... et al.Glans resurfacing for the treatment of carcinoma in situ of the penis: surgical technique and outcomes.Eur ...
Tópico(s): Urological Disorders and Treatments
2024 - Elsevier BV | ESMO Open
Jeffrey M. Holzbeierlein, Brooke R. Bixler, David Buckley, Sam S. Chang, Rebecca Holmes, Andrew James, Erin Kirkby, James M. McKiernan, Anne Schuckman,
... Committee on Cancer BLC Blue light cystoscopy CIS Carcinoma in situ LVI Lymphovascular invasion MRI Magnetic resonance imaging NBI ... cannot be assessed Ta Noninvasive papillary carcinoma Tis Carcinoma in situ (CIS) T1 Tumor invades lamina propria T2 Tumor ... systemic immunotherapy with pembrolizumab to a patient with carcinoma in situ (CIS) within 12 months of completion of adequate ... Crossref, Medline, Google Scholar 7. . Female gender and carcinoma in situ in the prostatic urethra are prognostic factors for ...
Tópico(s): Renal cell
2024 - Lippincott Williams & Wilkins | The Journal of Urology
Andrea Necchi, M. Roumiguié, Ashish M. Kamat, Neal D. Shore, Joost L. Boormans, Adil Esen, Thierry Lebrét, Shuya Kandori, Dean F. Bajorin, Laurence E. Krieger, Scot A. Niglio, Edward Uchio, Ho Kyung Seo, Ronald de Wit, Eric A. Singer, Petros Grivas, Hyeong Dong Yuk, Haojie Li, Pranshu Baranwal, Margot Van den Sigtenhorst-Fijlstra, Ekta Kapadia, Girish S. Kulkarni,
... declined radical cystectomy. In cohort A (patients with carcinoma in situ, with or without papillary tumours) of the KEYNOTE- ... cohort B of patients with papillary tumours without carcinoma in situ.
Tópico(s): Epigenetics and DNA Methylation
2024 - Elsevier BV | The Lancet Oncology
Karim Chamie, Sam S. Chang, Eugene V. Kramolowsky, Mark L. Gonzalgo, Megan Huang, Paul Bhar, Patricia Spilman, Lennie Sender, Sandeep K. Reddy, Patrick Soon‐Shiong,
... were assessed. Methods: Both cohort A patients with carcinoma in situ with or without Ta/T1 disease and cohort ... QUILT-3.032, patients with BCG-unresponsive bladder carcinoma in situ (CIS) with or without Ta/T1 papillary disease ( ... 5.98 Abbreviations: BCG, bacillus Calmette-Guérin; CIS, carcinoma in situ; CR, complete response (not baseline); ECOG, Eastern Cooperative ... 30.60 Abbreviations: BCG, bacillus Calmette-Guérin; CIS, carcinoma in situ; CR, complete response (not baseline); ECOG, Eastern Cooperative ...
Tópico(s): Epigenetics and DNA Methylation
2024 - Lippincott Williams & Wilkins | Urology Practice
James S. Krieger, Lawrence J. McCormack,
... of conization in the treatment of cervical in situ carcinoma in 414 patients treated in the period from Jan. ... per cent) failures of conization to control in situ carcinoma in the cervix. In 8 patients (1.8 per cent) in situ carcinoma has occurred simultaneously or sequentially in multiple foci ... Thus, all women for whom a diagnosis of in situ carcinoma has been made are entitled to systematic follow- ...
Tópico(s): Endometrial and Cervical Cancer Treatments
1968 - Elsevier BV | American Journal of Obstetrics and Gynecology
Jing Wang, Baizhou Li, Meng Luo, Jia Huang, Kun Zhang, Shu Zheng, Suzhan Zhang, Jiaojiao Zhou,
Abstract Ductal carcinoma in situ (DCIS) represents pre-invasive breast carcinoma. In untreated cases, 25–60% DCIS progress to invasive ductal carcinoma (IDC). The challenge lies in distinguishing between non-progressive and ...
Tópico(s): Breast Cancer Treatment Studies
2024 - Springer Nature | Signal Transduction and Targeted Therapy
Anoek H J Verschuur‐Maes, Carolien H. M. van Deurzen, Evelyn M. Monninkhof, P. J. van Diest,
... cancer precursors and are often associated with (in situ) carcinoma in excision specimens. Although several studies reported on the ... cancer precursors and are often associated with (in situ) carcinoma in excisions. This systematic review was conducted to provide ...
Tópico(s): Salivary Gland Tumors Diagnosis and Treatment
2011 - Lippincott Williams & Wilkins | Annals of Surgery
Minoru Takata, Akihide Fujimoto, Hiromasa Aoki, Naohito Hatta, Kazuhiko Takehara, Akishi Ooi,
... 85 y). The disease was entirely intraepidermal (in situ carcinoma) in 14 patients, and was accompanied by synchronous dermal ... in situ carcinomas, except in one recurrent in situ carcinoma. In contrast, 10 of 13 (77%) invasive primary tumors, ... FISH analysis were variable (Table I). A recurrent in situ carcinoma (case 14) showed strong membrane staining for erbB-2 in intraepidermal tumor cells most of which had more ...
Tópico(s): Cancer-related Molecular Pathways
1999 - Elsevier BV | Journal of Investigative Dermatology
Tibor Szalóki, Veronika Tóth, László Tiszlavicz, László Czakó,
... were analyzed.The initial forceps biopsies identified in situ carcinoma in 3 cases, adenoma with no dysplasia in 19, ... histological examination of the resected polyps revealed in situ carcinoma in 5 cases, carcinoid in 1, gastrointestinal stromal tumor ...
Tópico(s): Helicobacter pylori-related gastroenterology studies
2006 - Taylor & Francis | Scandinavian Journal of Gastroenterology
Johan A. Andersen, Michael Bachmann Nielsen, M Blichert-Toft,
The histopathological growth pattern of in situ carcinoma in the female breast is divided into three forms: 1) microfocal, 2) diffuse, and 3) tumour forming. This classification is clearly correlated to ...
Tópico(s): Cancer and Skin Lesions
1988 - Taylor & Francis | Acta Oncologica
Lijuan Tang, Yimeng Wang, Wenting Yan, Zhe Zhang, Siwen Luo, Qiaorui Wen, Shengfeng Wang, Niya Zhou, Qing Chen, Xu Yan,
... DEHP exposure and incidence of breast malignant neoplasm, carcinoma in situ and benign neoplasm. A total of 273,295 ... was associated with 1.11 fold risk of carcinoma in situ (95 % CI, 1.00, 1.23, p < 0. ... CI, 1.03, 1.07, p < 0.001), carcinoma in situ (HR, 1.08; 95 % CI, 1.04, 1. ...
Tópico(s): Microplastics and Plastic Pollution
2024 - Elsevier BV | The Science of The Total Environment
Mark D. Tyson, Edward Uchio, Jong-Kil Nam, Donald L. Lamm, Trinity J. Bivalacqua, Neal D. Shore, Wassim Kassouf, Gary D. Steinberg, Peter C. Black, Ashish M. Kamat, Hiroshi Kitamura, James M. Burke, Roger Li,
... BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER WITH CARCINOMA IN SITU Mark D. Tyson, Edward Uchio, Jong-Kil Nam, ... BCG-Unresponsive, Non-Muscle Invasive Bladder Cancer with Carcinoma in Situ (HR BCG-UR NMIBC with CIS). Cretostimogene grenadenorepvec ...
Tópico(s): Tissue Engineering and Regenerative Medicine
2024 - Lippincott Williams & Wilkins | The Journal of Urology
Zhenmei Yao, Ning Xu, Guoguo Shang, Hai Wang, Hui Tao, Yunzhi Wang, Zhaoyu Qin, Subei Tan, Jinwen Feng, Jiajun Zhu, Fahan Ma, Sha Tian, Qiao Zhang, Yuanyuan Qu, Jun Hou, Jianming Guo, Jian‐Yuan Zhao, Yingyong Hou, Chen Ding,
... a key signaling pathway in the progression of carcinoma in situ (CIS) and related to APOBEC signature. Glucolipid metabolism ...
Tópico(s): Genetic factors
2023 - Nature Portfolio | Nature Communications
Rita I. Demopoulos, Rima Aronov, Augusto F. Mesia,
... bilateral healed chronic salpingitis and arise from in situ carcinoma in a background of atrophy.
Tópico(s): Gynecological conditions and treatments
2001 - Lippincott Williams & Wilkins | International Journal of Gynecological Pathology
Hongzhong Jin, Shichong Liao, Feng Yao, Juanjuan Li, Zhiliang Xu, Kailiang Zhao, Ximing Xu, Shengrong Sun,
... or lobules in situ, it is called ductal carcinoma in situ (DCIS)/lobular carcinoma in situ (LCIS). The biggest risk factors are age, mutations ...
Tópico(s): Cancer Immunotherapy and Biomarkers
2023 - Multidisciplinary Digital Publishing Institute | Cancers
Roxanne A W Ploumen, Cornelis M. de Mooij, Suzanne Gommers, Kristien Keymeulen, Marjolein L. Smidt, Thiemo J. A. van Nijnatten,
... patients treated with neoadjuvant systemic therapy (NST), ductal carcinoma in situ (DCIS) is present. Recent studies suggest response of ... NST, further research is demanded. Key Points • Ductal carcinoma in situ has shown to be responsive to neoadjuvant systemic ...
Tópico(s): Medical Imaging Techniques and Applications
2023 - Springer Science+Business Media | European Radiology
Lorna D. Johnson, Charles L. Easterday, Hazel Gore, Arthur T. Hertig,
... Patten, S. F., Jr.: Developmental stages of in situ carcinoma in uterine cervix; analytical study of cells. Acta cytol. ...
Tópico(s): Global Cancer Incidence and Screening
1964 - Wiley | Cancer
Susan M. Pierce, Stuart J. Schnitt, Jay R. Harris,
... 2 Schnitt S., Harris J., Kinne D. In situ carcinoma. In: J Harris, S Hellman, I Henderson, D Kinne, ... M., Fracchia A., DePalo A., Rosen P. Breast carcinoma in situ. Arch Surg 1989; 124: 33–6. 5 Lagios ... F., Westdahl PR, Rose MR. Mammographically detected duct carcinoma in situ: frequency of local recurrence following tylectomy and prognostic ... 1989; 63: 618–24. 6 Lagios M. Duct carcinoma in situ: pathology and treatment. Surg Clin North Am 1990; ... T., Gibbs N. Management of screen detected ductal carcinoma in situ of the female breast. Br J Surg 1989; ...
Tópico(s): AI
1992 - Wiley | Cancer
Gabriella Fontanini, Silvana Vignati, D Bigini, Marco Lucchi, Alfredo Mussi, Fulvio Basolo, Carlo Alberto Angeletti, Generoso Bevilacqua,
... metaplastic epithelium than in dysplastic epithelium and in situ carcinoma. In particular, no differences were observed between normal and ... the latter and dysplastic lesions. Moderate dysplasia and in situ carcinoma showed a number of microvessels in the lamina ... component. Hyperplasia and squamous metaplasia, unlike dysplasia and in situ carcinoma, show a low microvessel count, and they cannot ...
Tópico(s): Lymphatic System and Diseases
1996 - Wiley | International Journal of Cancer
Yuanyuan Wu, Andrew Nguyen, Xiao-Xuan Wu, Mingyu Loh, Michelle N. Vu, Yiyu Zou, Qiang Liu, Peng Guo, Yanhua Wang, Leslie L. Montgomery, Amos Orlofsky, Jacob H. Rand, Elaine Y. Lin,
... Titer in Patients with Breast LesionsaPL statusCarcinoma in situ∗Carcinoma in situ includes both ductal and lobular carcinoma in situ.Invasive carcinoma†Invasive carcinoma includes invasive ductal or ... more positive outcomes were scored as aPL positive.∗ Carcinoma in situ includes both ductal and lobular carcinoma in situ.† Invasive carcinoma includes invasive ductal or lobular carcinoma.‡ P < 0. ...
Tópico(s): Monoclonal and Polyclonal Antibodies Research
2014 - Elsevier BV | American Journal Of Pathology
Jorge Albores‐Saavedra, Avissai Alcantra-Vazquez, Humberto Cruz-Ortíz, Roberto Herrera‐Goepfert,
... 5%, atypical hyperplasia and 3.5%, carcinoma in situ. Carcinoma in situ was also observed in the mucosa adjacent to ... toward atypical hyperplasia and that this progresses to in situ carcinoma which finally becomes invasive carcinoma. A simple cytologic ... recommended for the diagnosis of atypical hyperplasia and carcinoma in situ in excised gallbladders. Preoperative identification of these two ...
Tópico(s): Biliary and Gastrointestinal Fistulas
1980 - Wiley | Cancer
Lonzetta Neal, Cindy L. Tortorelli, Aziza Nassar,
... Google Scholar because the associated finding is in situ carcinoma in 2% of patients and the risk of invasive ... Lobular neoplasia includes the entities ALH and lobular carcinoma in situ, which are often found incidentally at biopsy.36Page ... for ALH and 8 to 10 for lobular carcinoma in situ.22Page DL Dupont WD Rogers LW Rados MS ... JF Update on atypical epithelial hyperplasia and ductal carcinoma in situ.Pathology. 2009; 41: 36-39Crossref PubMed Scopus (39) ... there is a 15% possibility that invasive or in situ carcinoma may be associated with this finding.25Putti TC ...
Tópico(s): Cancer and Skin Lesions
2010 - Elsevier BV | Mayo Clinic Proceedings
J. Rubén Rodríguez, Roberto Salvia, Stefano Crippa, Andrew L. Warshaw, Claudio Bassi, Massimo Falconi, Sarah P. Thayer, Gregory Y. Lauwers, Paola Capelli, Mari Mino–Kenudson, Oswaldo Razo, Deborah McGrath, Paolo Pederzoli, C Fernandez-del Castillo,
... 1 by borderline neoplasm, and 1 by in situ carcinoma). In 133 (96.4%) patients, the transection margin was ...
Tópico(s): Gallbladder and Bile Duct Disorders
2007 - Elsevier BV | Gastroenterology
Fazlul H. Sarkar, Brian J. Miles, David H. Plieth, John D. Crissman,
... and 18) in a morphological spectrum of in situ (carcinoma in situ) and invasive neoplasm of the penis. We studied 15 examples of carcinoma in situ [7 bowenoid and 8 nonbowenoid (squamoid or simplex)], ... detected in any of the nonbowenoid specimens of carcinoma in situ, the verrucous carcinoma, the adenocarcinoma or the papilloma ... However, all 7 of the bowenoid forms of carcinoma in situ were positive for human papillomavirus type 16 DNA. ...
Tópico(s): Urological Disorders and Treatments
1992 - Lippincott Williams & Wilkins | The Journal of Urology
Produção Nacional
Revisado por pares
Veerle Bossuyt, Elena Provenzano, W. Fraser Symmans, Fleur Webster, Kimberly H. Allison, Chau T. Dang, Helenice Gobbi, Janina Kulka, Sunil R. Lakhani, Takuya Moriya, Cecily Quinn, Anna Sapino, Stuart J. Schnitt, D.M. Sibbering, Elzbieta Slodkowska, Wentao Yang, Puay Hoon Tan, Ian O. Ellis,
... removed lymph nodes for breast tumours and ductal carcinoma in situ , variants of lobular carcinoma in situ and low‐grade lesions. The data set in ...
Tópico(s): Global Cancer Incidence and Screening
2024 - Wiley | Histopathology
Lavinia P. Middleton, George Vlastos, Nadeem Q. Mirza, S. Eva Singletary, Ayşegül A. Şahin,
... 97%). Approximately 72% of the cases had in situ carcinoma in both tumors and 44% had lymphovascular invasion. Comparative ...
Tópico(s): HER2/EGFR
2002 - Wiley | Cancer
Jill S. Gluskin, Michael Click, Richard C. Fleischman, Clarisse Dromain, Elizabeth A. Morris, Maxine S. Jochelson,
... skin contamination artifact on CEDM that mimics in-situ carcinoma in a case series.Five patients were identified whose ... apparent calcifications and non-mass enhancement suspicious for in-situ carcinoma, with no subsequent evidence of disease. Retrospective image ... of apparent enhancement similar to the appearance of in-situ carcinoma.Skin contamination with iodinated contrast can result in ... contrast digital mammography that mimics the appearance of in-situ carcinoma.
Tópico(s): Advanced X-ray and CT Imaging
2017 - Elsevier BV | European Journal of Radiology